Macleods Pharmaceuticals Limited IPO has been filed with the capital market regulator SEBI for Rs.5,000 crore. This is going to be the second most IPO that has been raised by a Pharma after Gland’s Pharma Rs.6,480 Cr issue. Macleods Pharmaceuticals Limited is one of the seventh-largest drug pharma companies in the Indian Pharmaceutical Market.
Established in 1989, Macleods Pharmaceuticals are into developing, manufacturing and marketing an extensive range of pharmaceutical products. Their product portfolio includes the major therapeutic areas like anti-infectives, cardiovascular, dermatology, hormone treatment, etc. The brand has the highest number of WHO prequalified products globally with 65 registrations.
The brand has an extensive presence across the globe. Macleods Pharmaceuticals is present in more than 170 countries such as Africa, Europe, Asia, North America, etc. In India, the operations are supported by eight manufacturing units. The 8 manufacturing units have a vast range of oral dosage forms and complex formulations, such as topicals, injectables and inhalers.
Listing at NSE, BSE
|IPO Open Date||To be announced|
|IPO Close Date||To be announced|
|Allotment Date||To be announced|
|Initiation Of Refunds||To be announced|
|Credit Of Shares To
|To be announced|
|IPO Listing Date||To be announced|
|UPI Mandate Expiry Date||To be announced|
|Revenue from operations||58,704.35||69,028.16||71,994.16|
|Fixed Asset Turnover||6.10||6.68||5.69|
A simple and smartest way to apply in IPO online via Religare Dynami Mobile App
Below are your top reasons:
The brand has a strong R&D resulting in an amazing track record of product innovation and product launches
Their in-house packaging material unit helps the company in quality checks and quality control across the various stages of operations.
The company has an experienced and professional management team that helps in building brands
The company is one of the leading and fastest-growing companies, being among the top 10 Indian pharmaceutical companies
The company has a diversified presence across the global market existing in 170 countries
Any shortfall of raw materials or an increase of price, may affect the business
Any pharma manufacturers are subject to significant regulatory scrutiny. The introduction of any law from the regulatory bodies can impact the business adversely.
Changes in government regulation can affect the business
As the brand is dependent on third-party manufacturers, any delays or disruptions in the manufacturing facilities will affect the business
As the brand is heavily dependent on R&D, any setback in the department can affect the company
Retail investors need to apply for the IPO using UPI
Fill up your personal details in the form above
Fill up your DOB, PAN, email & bank account details
Upload your photo and e-sign your application via Aadhaar OTP
Macleods Pharmaceuticals Limited IPO has been filed with the capital market regulator SEBI for Rs.5,000 crore.
There is no announcement regarding the date of allotment.
Details regarding the lot size of the IPO aren’t announced.
Listing gain is the difference between the IPO's opening and offer prices.
The listing gain results from changing investors' interests, global parameters, and short vs long-term outlooks.
The bank initially blocks the amount you bid for an IPO. It will debit the amount when the shares get allotted or unblock it after the UPI mandate expiry date.
You can submit only one application using one PAN card.
Login to your UPI handle and approve the payment mandate to complete the IPO application process.
Details are not available.
Details are not available.
The minimum investment size is one lot for retail investors.
It usually takes ten working days from the last day of subscription to list the IPO on the bourses.
Dynami customers can log in to their accounts to check Uma Converter Limited IPO. IPO allotment status.
When checking the allotment status, keep your application, DP ID, and PAN number ready.
The minimum size of the application will be one lot.